Safe Pro Group Inc. (SPAI)
Nasdaq: SPAI · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Aventura, FL · filing with the SEC since 2024
Income statement, as filed
In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
| Report filed | Mar 31, 2026 | Mar 31, 2025 | · | · |
| Revenue | 606,681 | 2,169,178 | 917,720 | · |
| Cost of revenue | 404,503 | 1,263,032 | 606,639 | · |
| Gross profit | 202,178 | 906,146 | 311,081 | · |
| Research and development | 394,207 | 90,372 | 373,655 | · |
| Selling, general and administrative | 2,131,056 | 1,254,772 | 449,874 | · |
| Total operating expenses | 14,747,707 | 8,058,147 | 6,618,011 | · |
| Operating income | -14,545,529 | -7,152,001 | -6,306,930 | · |
| Interest expense | 12,833 | 306,516 | 8,227 | · |
| Interest and investment income | 178,476 | 30,056 | 508 | · |
| Total non-operating income (expense) | 222,750 | -276,460 | -7,719 | · |
| Net income | -14,322,779 | -7,428,461 | -6,314,649 | · |
| Earnings per share, basic | -0.85 | -0.70 | -0.79 | · |
| Earnings per share, diluted | -0.85 | -0.70 | -0.79 | · |
| Weighted average shares, basic | 16,906,724 | 10,613,270 | 7,984,743 | · |
| Weighted average shares, diluted | 16,906,724 | 10,613,270 | 7,984,743 | · |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfRevenueGross profit revenue less the cost of what it sold
us-gaap:GrossProfitResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSelling, general and administrative the cost of selling and of running the company
us-gaap:SellingGeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseNonoperatingInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding